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Abstract
Rationale: Understanding the genetic variations among Mycobacterium tuberculosis (MTB) strains with differential ability to
transmit would be a major step forward in preventing transmission.
Objectives: To describe a method to extend conventional proxy measures of transmissibility by adjusting for patient-related
factors, thus strengthening the causal association found with bacterial factors.
Methods: Clinical, demographic and molecular fingerprinting data were obtained during routine surveillance of verified
MTB cases reported in the Netherlands between 1993 and 2011, and the phylogenetic lineages of the isolates were inferred.
Odds ratios for host risk factors for clustering were used to obtain a measure of each patient’s and cluster’s propensity to
propagate (CPP). Mean and median cluster sizes across different categories of CPP were compared amongst four different
phylogenetic lineages.
Results: Both mean and median cluster size grew with increasing CPP category. On average, CPP values from Euro-American
lineage strains were higher than Beijing and EAI strains. There were no significant differences between the mean and
median cluster sizes among the four phylogenetic lineages within each CPP category.
Conclusions: Our finding that the distribution of CPP scores was unequal across four different phylogenetic lineages
supports the notion that host-related factors should be controlled for to attain comparability in measuring the different
phylogenetic lineages’ ability to propagate. Although Euro-American strains were more likely to be in clusters in an
unadjusted analysis, no significant differences among the four lineages persisted after we controlled for host factors.
Citation: Nebenzahl-Guimaraes H, Borgdorff MW, Murray MB, van Soolingen D (2014) A Novel Approach - The Propensity to Propagate (PTP) Method for
Controlling for Host Factors in Studying the Transmission of Mycobacterium Tuberculosis. PLoS ONE 9(5): e97816. doi:10.1371/journal.pone.0097816
Editor: Olivier Neyrolles, Institut de Pharmacologie et de Biologie Structurale, France
Received February 24, 2014; Accepted April 24, 2014; Published May 21, 2014
Copyright:  2014 Nebenzahl-Guimaraes et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which
permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: Portuguese Foundation for Science and Technology (FCT) (SFRH/BD/33902/2009 to HN-G). The funders had no role in study design, data collection and
analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: hanna.guimaraes@gmail.com
Introduction
Transmission of Mycobacterium tuberculosis (MTB) occurs through
aerosol droplets. Subsequent cases in transmission chains result in
‘‘clusters’’ of patients who share Mtb strains of the same genotype
or molecular fingerprint [1]. Cluster sizes vary widely, which may
reflect the fact that strains do not spread equally or that they differ
in their rate of progression to active TB disease. The identification
of strains that cause large tuberculosis (TB) outbreaks, such as
CDC1551 or Harlingen [2,3], has lead to studies on the virulence
of such strains. Indeed molecular epidemiologic studies have
suggested that some strains are more successfully transmitted than
others [4–6]. The mechanisms however governing this variability
remain largely unknown, with much research focused on the
contribution of host risk factors. In the Netherlands for example,
age, sex, homelessness, alcohol or drug abuse, living in an urban
area and smear positivity have all been associated to increased
transmissibility [7]. There is substantial evidence however to
suggest that bacterial factors also contribute to variability in cluster
size and the extent of transmission of TB. For example, Verhagen
and colleagues showed that newly diagnosed index cases in a
larger cluster infected more people than did newly diagnosed cases
in smaller clusters [8]. This implies that clusters not only grow over
time because of well-known patient risk factors for TB transmis-
sion, but also because the strain itself generates an increased
number of tuberculin skin test-positive contacts, and spreads more
effectively than other strains.
Phylogenetic lineages reflect evolutionary divergence associated
with different geographical regions [9]. Beijing lineage strains, for
example, are predominantly found in Asia, yet are widely
PLOS ONE | www.plosone.org 1 May 2014 | Volume 9 | Issue 5 | e97816disseminated and present in more countries than any other lineage
strain. This suggests that this evolutionary lineage may have
evolved unique properties leading to its successful clonal expansion
[10,11]. To date, studies examining the association between
phylogenetic lineages of MTB and transmissibility have typically
used DNA fingerprinting clustering rates as measures of transmis-
sibility, with very few adjusting for host-related factors.
Since preventing transmission of MTB is key to a sustained
decline in TB incidence, understanding the genetic variations
between strains with differential ability to transmit would be a
major step forward. In order to distinguish bacterial factors
associated with transmission from those that pertain to the host
however, the influence of host-related factors needs to be
addressed. In the Netherlands, a nationwide surveillance of TB
including structural DNA fingerprinting of all M. tuberculosis
isolates has been in place since 1993. Patient information is
available for all registered TB cases, of which there are
approximately one thousand per year. Here, we describe a
method to complement and extend the conventional use of cluster
size and proportion of cases in a cluster as proxy measures of
transmissibility by adjusting for patient related factors, thus
strengthening the causal association found with bacterial factors.
Since cluster size may reflect both the propensity of a strain to be
transmitted and to cause disease given an infection, we have
chosen to use the term ‘‘propagation’’ instead of transmissibility as
a more accurate description of cluster growth.
Methods
Data Collection and DNA Fingerprinting
The National Institute for Public Health and the Environment
(RIVM) in Bilthoven, The Netherlands, serves as a reference
laboratory for the secondary laboratory diagnosis of all TB cases in
The Netherlands, offering identification, drug susceptibility
testing, and molecular typing. DNA fingerprints of all nationwide
MTB complex isolates and their cluster status have been stored in
Figure 1. Flow-diagram of exclusion criteria applied to dataset.
doi:10.1371/journal.pone.0097816.g001
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Netherlands Tuberculosis Register (NTR) approved this retro-
spective study and provided demographic and clinical information
for patients. Because these data are de-identified by name, DNA
fingerprinting results from the RIVM were linked on the basis of
sex, date of birth, year of diagnosis and postal code. All notified
MTB culture-positive cases between 1993 and 2011 were included
in the study. In case of patients with multiple isolates, only the
isolate with the earliest date of diagnosis was included. Contam-
inated isolates were excluded from the database.
Isolates recovered from patients between 1993 and 2009
underwent IS6110 and polymorphic GC-rich sequence (PGRS)
restriction fragment length polymorphism (RFLP) typing
(n=15,073), and those from 2004 onward to variable number of
Table 1. Host risk factors for clustering of MTB in the Netherlands, 1993–2011.
No. (%) in clustering state:
Category and case group Clustered Non-clustered OR (95% CI)
Adjusted OR (95%
CI)
Sex Males 5385 (60.8) 3474 (39.2) 1 (Ref) 1 (Ref)
Females 3200 (53.5) 2779 (46.5) 0.74 (0.70–0.79) 0.87 (0.81–0.93)
Age at diagnosis (years) 0–15 366 (69.2) 163 (30.8) 1.28 (1.11–1.56) 1.05 (0.86–1.29)
16–30 3383 (63.7) 1929 (36.3) 1 (Ref) 1 (Ref)
31–45 2485 (60.9) 1593 (39.1) 0.89 (0.82–0.97) 0.86 (0.78–0.94)
46–60 1254 (59.5) 852 (40.5) 0.84 (0.76–0.93) 0.77 (0.69–0.86)
61–75 715 (45.1) 871 (54.9) 0.47 (0.42–0.52) 0.40 (0.35–0.45)
76–90 370 (31.6) 800 (68.4) 0.26 (0.23–0.30) 0.19 (0.17–0.23)
.90 12 (21.1) 45 (78.9) 0.15 (0.08–0.29) 0.12 (0.06–0.22)
Disease Classification Pulmonary 5107 (61.6) 3187 (38.4) 1 (Ref) 1 (Ref)
Extrapulmonary 2465 (51.2) 2347 (48.8) 0.66 (0.61–0.70) 0.76 (0.69–0.83)
Pulmonary-extrapulmonary 1013 (58.5) 719 (41.5) 0.88 (0.79–0.98) 0.90 (0.80–1.01)
Smear-positivity No 5068 (54.7) 4205 (45.3) 1 (Ref) 1 (Ref)
Yes 3517 (63.2) 2048 (36.8) 1.43 (1.33–1.53) 1.17 (1.07–1.27)
Alcohol consumption No 8426 (57.6) 6200 (42.4) 1 (Ref) 1 (Ref)
Yes 159 (75.0) 53 (25.0) 2.20 (1.61–3.01) 1.29 (0.92–1.80)
Drug-use No 8213 (57.0) 6193 (43.0) 1 (Ref) 1 (Ref)
Yes 372 (86.1) 60 (13.9) 4.67(3.55–6.15) 2.75 (2.05–3.67)
Homelessness No 8362 (57.4) 6198 (42.6) 1 (Ref) 1 (Ref)
Yes 223 (80.2) 55 (19.8) 3.0 (2.23–4.04) 1.58 (1.15–2.18)
Health-care worker No 8463 (57.8) 6187 (42.2) 1 (Ref) 1 (Ref)
Yes 122 (64.9) 66 (35.1) 1.35 (1.00–1.83) 1.00 (0.73–1.38)
Traveler to endemic areas No 8423 (58.0) 6090 (42.0) 1 (Ref) 1 (Ref)
Yes 162 (49.8) 163 (50.2) 0.72 (0.58–0.90) 0.58 (0.46–0.73)
Origin Native Dutch 2343 (58.4) 1667 (41.6) 1 (Ref) 1 (Ref)
Foreign-born (Asia) 1247 (39.0) 1949 (61.0) 0.41 (0.37–0.45) 0.28 (0.25–0.31)
Foreign-born (Africa) 3253 (65.0) 1749 (35.0) 1.18 (1.09–1.29) 0.76 (0.69–0.84)
Foreign-born (America) 704 (72.1) 273 (27.9) 1.64 (1.41–1.91) 1.06 (0.90–1.25)
Foreign-born (Europe) 415 (53.1) 366 (46.9) 0.72 (0.62–0.84) 0.43 (0.37–0.51)
Total cases 8585 (57.9) 6253 (42.1)
OR, odds ratio; CI, confidence interval; Statistically significant OR are highlighted in bold.
doi:10.1371/journal.pone.0097816.t001
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2004–2008 both RFLP and VNTR typing were performed [14].
In addition, 4,433 randomly selected isolates were spoligotyped.
We defined a cluster as groups of patients who shared TB isolates
with identical RFLP or VNTR patterns or, if strains had fewer
than five IS6110 copies, identical PGRS RFLP patterns [15].
Classification into phylogenetic lineages
The phylogenetic label of a spoligotyped isolate was used to
infer the lineage of isolates belonging to the same RFLP or VNTR
cluster as the spoligotyped isolate. Following this, the MIRU-
VNTRplus online tool was used to perform MIRU Best Match
Analysis (stringent cut-off of 0?17) followed by MIRU Tree-based
identification to identify the phylogenetic lineages of strains with
MIRU patterns [16]. Resulting matched phylogenetic lineages
from clustered isolates were extrapolated to the remaining isolates
of the respective clusters. Remaining strains without an inferred
lineage were assigned one on the basis of RFLP similarity ($80%)
to a reference dataset of pre-identified strains with RFLP patterns
in a tree generated by the neighbor-joining method with the
Kimura 2 parameter on BioNumerics software for Windows
(version 6?6, Applied Maths). The same procedure was repeated
for strains with RFLP PGRS patterns. Finally, any remaining
MIRU-typed strains without an inferred lineage were subjected to
MIRU Best Match Analysis (relaxed cut-off of 0?3). This was
purposely left as the last in the series of steps for the classification of
lineages as it is the least optimized for minimizing fine-tuned
mismatching that can occur as an exception among strains
belonging to the Euro-American family [17].
Four major phylogenetic lineages were identified: Euro-Amer-
ican, Central Asian Strain (CAS), East-African-Indian (EAI) and
Beijing (Table S1). Strains not assigned a phylogenetic lineage or
assigned more than one major phylogenetic family per cluster were
excluded from analysis. Strains classified as either ‘‘T’’ or ‘‘U’’
(Unknown) were also excluded due to the ambiguity of these
classifications (Figure 1).
We considered the possibility that the use of spoligotyping,
MIRU- or RFLP-typing for inferring phylogenetic lineages in this
study may have resulted in misclassification of lineage, due to the
propensity of these markers for convergent evolution and resulting
homoplasies [18]. To assess this, we compared the inferred
phylogenetic lineages with those determined using single nucleo-
tide polymorphisms (SNP) markers in a subset of strains (n=248)
that were also whole-genome sequenced [19].
Statistical Analysis
We used a logistic regression model to determine independent
host risk factors including demographic, behavioral, and sputum
smear status, for clustering. Variables with p-values ,0?20 were
entered into a multivariate model. Crude and adjusted odds ratios
(OR) are presented with 95% confidence intervals (CI). Estimates
for the adjusted ORs were each multiplied as weights to calculate
each patient’s propensity to propagate (PPP). The geometric mean
of PPP values belonging to a cluster was taken as the overall
measure of a cluster’s propensity to propagate (CPP). Confidence
intervals for the median CPP by phylogenetic lineage were
calculated using nonparametric bootstrapping methods based on
10,000 replicates. An analysis of variance (ANOVA) with
Bonferroni correction was performed to determine CPP compa-
rability among the four phylogenetic lineages. We repeated this
step on a validation subset of strains (n=2,136) whose lineages
were determined using the highly reliable MIRU Best Match
Analysis (stringent cut-off) and SNP markers [9]. We also explored
the variability of CPP by phylogenetic lineage stratified by host
region of origin, by repeating the ANOVA on a subset of clusters
composed of patients of a particular region only (Europe versus
Asia). In a sensitivity analysis, we checked the consequences of
excluding extra-pulmonary cases from the dataset. Finally, the
proportion of clustered isolates was calculated for each phyloge-
netic lineage. Mean and median cluster size (plus interquartile
ranges and 95% CI, respectively) were calculated for three
increasing CPP categories (,0?5, 0?5–0?8 and .0?8) for each of
the four phylogenetic lineages. SAS software for Windows, version
9?3, was used for statistical analyses.
Results
During the period January 1993 to December 2011, 18,294
isolates were collected from 18,274 notified TB cases in the
Netherlands and their clustering status ascertained, of which
15,601 (85%) were successfully matched with the NTR data. Of
these, 14,838 (94%) were non-contaminated MTB cultures with
completely ascertained information on host risk factors (Figure 1).
The mean age of MTB positive TB cases was 41 years (SD, 20);
8,859 (60%) were male; and 10,005 (67%) were foreign-born.
Host-related factors for clustering
Of the 14,838 strains with both DNA fingerprinting and host-
related data, 8,585 were clustered (57?9%) and 6,253 were non-
clustered (42?1%). Table 1 shows that patients were more likely to
be in a cluster if they were smear-positive, had a pulmonary
manifestation and were younger, male, alcohol or IV drug users,
homeless, a health-care worker, native Dutch or foreign-born from
Africa or the Americas. Patients were less likely to be in a cluster if
they had travelled to an endemic area in the past two months or
were foreign-born from Asia or Europe. In the multivariate model,
all risk factors for clustering remained significant with the
exception of alcohol consumption, being a health-care worker or
being a foreign-born from the Americas. Being a foreign-born
from Africa turned into a protective factor against clustering after
adjustment in multivariate analysis. Resulting values for PPP and
CPP ranged from 0 (a low risk profile for clustering, i.e. an elderly
female patient with extra-pulmonary, smear-negative TB and no
Figure 2. Distribution of Propensity to Propagate values.
doi:10.1371/journal.pone.0097816.g002
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years) male patient with pulmonary, smear-positive TB and at
least one behavioral risk factor), with the distribution of CPP
values skewed to the right of PPP values from patients with unique
isolates (Figure 2).
Host-related factors by phylogenetic lineage
Of the 10,389 M. tuberculosis isolates which had both a CPP and/
or PPP value and an assigned phylogenetic lineage, 6,595 were
classified as Euro-American (63?5%), 1,327 as CAS (12?8%), 1,422
as EAI (13?7%) and 1,045 as Beijing (10?0%). The excluded 15%
of strains that were not matched with the NTR data fall into a
similar lineage distribution. Lineage misclassification was estimat-
ed at 19%, with 200 out of 248 strains in this study having
concordant lineage classifications to SNP-based inferences. Of the
10,389 strains, 4,491 (43?2%) were non-clustered and the
remainder consisted of 1,505 clusters, representing 175 CAS
clusters, 972 Euro-American, 202 EAI and 156 Beijing. Median
values for CPP were 0?64 (95% CI: 0?57–0?67), 0?76 (95% CI:
0?73–0?77), 0?75 (95% CI: 0?71–0?76) and 0?72 (95% CI: 0?70–
0?73) for Beijing, Euro-American, CAS and EAI strains. CPP
values from strains of the Euro-American lineage were on average
higher than those of Beijing and EAI strains, and CAS strains were
also on average higher than EAI strains at a 0?05 level of
significance (Figure 3). CPP values of strains belonging to the
validation subset of strains classified using high reliability markers
showed a similar trend, with the median CPP of strains of the
Euro-American lineage remaining on average higher than those of
Beijing and EAI strains at a 0?05 level of significance. Repeating
the ANOVA on clusters composed of patients of European origin
only (n=277) showed a significantly lower mean CPP in clusters of
the Euro-American strain (0?73; 95% CI: 0?70–0?76) compared to
that of in clusters of Beijing (0?89; 95% CI: 0?80–0?98) or CAS
(0?86; 95% CI: 0?77–0?96) strains, at a 0?05 level of significance.
In the subset of clusters composed of patients of Asian origin only
(n=57), mean CPP values were 0?46 (95% CI: 0?43–0?49), 0.40
(95% CI: 0?32–0?48), 0?40 and 0?43 (95% CI: 0?39–0?47), for
Beijing, Euro-American, CAS (n=1) and EAI strains, respectively.
Excluding extra-pulmonary cases (n=4,812) from the dataset and
logistic regression model resulted in Beijing strains maintaining the
lowest median CPP (0?71, 95% CI: 0?65–0?78) compared to that
of Euro-American (0?85, 95% CI: 0?82–0?85), CAS (0?84, 95%
CI: 0?80–0?85) and EAI (0?83, 95% CI: 0?75–0?86) strains.
Propagation by phylogenetic lineage
The proportion of clustered isolates was 60?7% (95% CI, 59?5–
61?9) for Euro-American strains, 49?2% (95% CI, 46?5–51?9) for
CAS strains, 51?1% (95% CI, 48?5–53?7) for EAI strains and
49?4% (95% CI, 46?4–52?4) for Beijing strains. Both minimum
and average PPP/CPP per cluster size increased with rising
cluster size (Figure 4). Likewise, mean and median cluster size
grew with increasing CPP category (Figure 5). There were no
significant differences between the mean and median values of
cluster size between the four phylogenetic lineages within each
CPP category.
Figure 3. Distribution of Cluster Propensity to Propagate by 4
Phylogenetic Lineages. * 0.05 Level of Significance. Q1 – Lower
Quartile; Q3 – Upper Quartile.
doi:10.1371/journal.pone.0097816.g003
Figure 4. Distribution of Propensity to Propagate by Cluster Size.
doi:10.1371/journal.pone.0097816.g004
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In this long-term Netherlands-based study, we compared the
propensity to propagate of four major MTB lineages using a novel
method designed to differentiate host and bacterial factors
associated with strain transmissibility and progression. We found
that although Euro-American strains were more likely to be found
in clusters in an unadjusted analysis, no significant differences
among the four different lineages persisted after we controlled for
host factors.
The range of host factors associated with clustering that we
identified in this study include demographic (age, gender and
geographic origin), clinical (pulmonary manifestation and smear-
positivity) and behavioral (drug-use, homelessness) determinants
that have been identified in previous studies in this (and other)
settings [7,20]. The clearly skewed distribution of cluster CPP
values to the right of PPP values from patients with unique isolates
confirms the role of host-related factors in propagation. The
method described in this study to correct for host-related factors in
transmission enables the identification of highly propagating
strains (i.e. belonging to a larger than average cluster size for its
CPP score) from non-propagating ones (i.e. non-clustered isolates
with a high PPP). This selection process is useful to hone in on a
crisp phenotype that is necessary to study bacterial factors
associated with transmission, by means of genomic comparison
in future whole-genome sequencing studies [21]. It would for
example be interesting to subject the CDC1551 outbreak to our
new approach in order to separate host risk factors from the true
bacteriological component.
Our finding that the distribution of Cluster Propensity to
Propagate scores was not equal across the Euro-American, Beijing,
CAS and EAI lineages supports the notion that host-related factors
need to be controlled for in order to attain comparability in
measuring the ability of different phylogenetic lineages to
propagate. Other previous studies in low prevalence settings such
as Montreal and San Francisco have found the EAI lineage to be
associated with lower rates of transmission [22], and the Euro-
American lineage three times more likely to cause a secondary case
[23]. The former adjusted their OR for clustering for age, whilst
the rate measure used in the latter did not adjust for host-related
factors. Discrepancies between results from studies measuring
transmissibility between phylogenetic lineages may therefore partly
be due to differences in how and if host-related factors are
controlled for at all. This also seems important in the light of
studies on co-evolution between bacteria and hosts; to facilitate a
meaningful interpretation such studies should take patient risk
factors for transmission and breakdown to disease into consider-
ation [24]. In high prevalence settings this may be especially
challenging.
A major strength of our study was the use of a large sample size
over a long time period to accurately quantify the contribution of
host-related factors in clustering within this setting. With 69% of
patients being foreign-born from 159 different countries, our study
sample is also globally representative; given the phylogeographic
diversity of the major MTB lineages this is crucial to perform
comparative analyses to identify associations between strain
lineages and transmissibility. There is also an advantage in
conducting this analysis in a low prevalence setting such as the
Netherlands where the majority of people are susceptible and not
vaccinated with BCG. This means that cluster sizes more closely
reflect the biological underpinning of increased transmissibility
rather than the proportion of the population that is still susceptible
to MTB. Finally, our use of mean and median cluster size
(therefore excluding non-clustered strains) across CPP categories
instead of clustering rates decreases possible bias from the over-
representation of foreign-born patients, associated with non-
clustered strains from reactivation of latent TB infections acquired
before immigration, among non-Euro-American strains (74?3%,
95% CI: 73?0–75?6) versus Euro-American strains (53?3%, 95%
CI: 52?2–54?4).
Although our results contrast with those from studies carried out
in other populations where Beijing has been associated with
greater virulence and transmissibility [25–27], they are consistent
with those from other low incidence immigrant-receiving settings
such as the United States and Canada where it was concluded that
Beijing strains do not pose more of a public health threat than
non-Beijing strains [23,28]. The successful spread of this genotype
in Asia and other parts of the world may therefore be related to a
higher ability to withstand exposure to antituberculosis drugs and
BCG vaccination, rather than a higher ability to propagate
[11,29].
Figure 5. Distribution of Cluster Propensity to Propagate by Cluster Size and 4 Phylogenetic Lineages.
doi:10.1371/journal.pone.0097816.g005
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specific human population are not adapted to transmit and cause
secondary cases [23]. In Sweden for example, despite the close
proximity to Russia and the Baltic states, Beijing was found to
have a lower clustering rate, no absolute increase in number over
time and very little observed transmission from immigrants to
indigenous population [30]. In our study, there was no statistically
significant difference between the median and mean cluster sizes of
Beijing versus Euro-American strains after taking host propensity
to propagate factors into account. This was also found to be the
case for EAI and CAS strains, which suggests that imported strains
in the Netherlands are not necessarily less adapted to the native
host population and are just as likely to propagate as locally
occurring strains of the Euro-American lineage. A lower mean
CPP of Euro-American versus non-Euro-American strains found
in clusters of European origin only suggests the possibility of co-
evolution between phylogenetic lineages to their sympatric host
population, as has been previously reported [23]. No significant
differences were found however between CPP of phylogenetic
lineages in clusters of Asian origin only, which may reflect the
smaller sample size and reduced power to detect such an
association.
The inclusion of M. africanum isolates, which have been
associated with a lower rate of disease transmission compared to
other MTB strains [31], for comparison in our study was not
possible due to the very small number of patients infected with this
strain. A differential representation of lineages amongst the native
Dutch (who are not BCG vaccinated or previously exposed) versus
the foreign-born population also represents a possible source of
bias. In this dataset, the percentage of lineages circulating in the
native Dutch were 7.6%, 10.4%, 25.3% and 36.7% in the CAS,
EAI, Beijing and Euro-American lineages, respectively. It should
also be noted that the weights used to calculate each patient’s
propensity to propagate (PPP) in this study depended on the
clustering status given by molecular epidemiology data (RFLP-
and VNTR-typing) alone, whose accuracy is limited.
In sum, this study demonstrates the importance of controlling
for host-related factors in measuring the transmissibility of strains
and describes a method to do so in order to identify bacterial
factors in future studies. It also shows that there are no significant
differences in the ability to propagate of four main phylogenetic
lineages in the Netherlands, which is indicative that the spread of
imported strains (most often of the EAI, CAS and Beijing lineages)
is not necessarily curbed by a lack of adaptation to the native host
population.
Supporting Information
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